Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.561 | 0.760 | 6 | 32183666 | missense variant | C/T | snv | 5.3E-02 | 3.6E-02 | 0.100 | 1.000 | 12 | 2001 | 2016 | ||||
Coronary Artery Disease
|
1577 | 0.561 | 0.760 | 6 | 32183666 | missense variant | C/T | snv | 5.3E-02 | 3.6E-02 | 0.100 | 0.900 | 10 | 2007 | 2016 | ||||
Chronic Obstructive Airway Disease
|
852 | 0.561 | 0.760 | 6 | 32183666 | missense variant | C/T | snv | 5.3E-02 | 3.6E-02 | 0.760 | 1.000 | 8 | 2012 | 2019 | ||||
Diabetes
|
710 | 0.561 | 0.760 | 6 | 32183666 | missense variant | C/T | snv | 5.3E-02 | 3.6E-02 | 0.070 | 0.714 | 7 | 2001 | 2016 | ||||
Diabetes Mellitus
|
824 | 0.561 | 0.760 | 6 | 32183666 | missense variant | C/T | snv | 5.3E-02 | 3.6E-02 | 0.070 | 0.714 | 7 | 2001 | 2016 | ||||
Diabetic Retinopathy
|
213 | 0.561 | 0.760 | 6 | 32183666 | missense variant | C/T | snv | 5.3E-02 | 3.6E-02 | 0.070 | 0.857 | 7 | 2003 | 2016 | ||||
Coronary heart disease
|
1178 | 0.561 | 0.760 | 6 | 32183666 | missense variant | C/T | snv | 5.3E-02 | 3.6E-02 | 0.050 | 0.600 | 5 | 2007 | 2016 | ||||
Breast Carcinoma
|
2793 | 0.561 | 0.760 | 6 | 32183666 | missense variant | C/T | snv | 5.3E-02 | 3.6E-02 | 0.040 | 1.000 | 4 | 2014 | 2017 | ||||
Carcinoma of lung
|
1204 | 0.561 | 0.760 | 6 | 32183666 | missense variant | C/T | snv | 5.3E-02 | 3.6E-02 | 0.040 | 1.000 | 4 | 2013 | 2018 | ||||
Coronary Arteriosclerosis
|
440 | 0.561 | 0.760 | 6 | 32183666 | missense variant | C/T | snv | 5.3E-02 | 3.6E-02 | 0.040 | 0.750 | 4 | 2007 | 2016 | ||||
Malignant neoplasm of breast
|
3417 | 0.561 | 0.760 | 6 | 32183666 | missense variant | C/T | snv | 5.3E-02 | 3.6E-02 | 0.040 | 1.000 | 4 | 2014 | 2017 | ||||
Malignant neoplasm of lung
|
1142 | 0.561 | 0.760 | 6 | 32183666 | missense variant | C/T | snv | 5.3E-02 | 3.6E-02 | 0.040 | 1.000 | 4 | 2013 | 2018 | ||||
Neoplasms
|
1644 | 0.561 | 0.760 | 6 | 32183666 | missense variant | C/T | snv | 5.3E-02 | 3.6E-02 | 0.040 | 1.000 | 4 | 2014 | 2018 | ||||
Primary malignant neoplasm of lung
|
981 | 0.561 | 0.760 | 6 | 32183666 | missense variant | C/T | snv | 5.3E-02 | 3.6E-02 | 0.040 | 1.000 | 4 | 2013 | 2018 | ||||
Asthma
|
1536 | 0.561 | 0.760 | 6 | 32183666 | missense variant | C/T | snv | 5.3E-02 | 3.6E-02 | 0.030 | 1.000 | 3 | 2011 | 2019 | ||||
Ischemic stroke
|
704 | 0.561 | 0.760 | 6 | 32183666 | missense variant | C/T | snv | 5.3E-02 | 3.6E-02 | 0.030 | 1.000 | 3 | 2013 | 2017 | ||||
Malignant Neoplasms
|
1641 | 0.561 | 0.760 | 6 | 32183666 | missense variant | C/T | snv | 5.3E-02 | 3.6E-02 | 0.030 | 1.000 | 3 | 2015 | 2018 | ||||
Primary malignant neoplasm
|
1374 | 0.561 | 0.760 | 6 | 32183666 | missense variant | C/T | snv | 5.3E-02 | 3.6E-02 | 0.030 | 1.000 | 3 | 2015 | 2018 | ||||
Respiratory Function Tests
|
108 | 0.561 | 0.760 | 6 | 32183666 | missense variant | C/T | snv | 5.3E-02 | 3.6E-02 | 0.700 | 1.000 | 3 | 2010 | 2012 | ||||
Retinal Diseases
|
56 | 0.561 | 0.760 | 6 | 32183666 | missense variant | C/T | snv | 5.3E-02 | 3.6E-02 | 0.030 | 0.333 | 3 | 2012 | 2013 | ||||
Rheumatoid Arthritis
|
2387 | 0.561 | 0.760 | 6 | 32183666 | missense variant | C/T | snv | 5.3E-02 | 3.6E-02 | 0.710 | 1.000 | 3 | 2007 | 2011 | ||||
Alzheimer's Disease
|
1843 | 0.561 | 0.760 | 6 | 32183666 | missense variant | C/T | snv | 5.3E-02 | 3.6E-02 | 0.020 | 1.000 | 2 | 2010 | 2010 | ||||
Cardiovascular Diseases
|
711 | 0.561 | 0.760 | 6 | 32183666 | missense variant | C/T | snv | 5.3E-02 | 3.6E-02 | 0.020 | 0.500 | 2 | 2005 | 2007 | ||||
Chronic kidney disease stage 5
|
194 | 0.561 | 0.760 | 6 | 32183666 | missense variant | C/T | snv | 5.3E-02 | 3.6E-02 | 0.020 | 1.000 | 2 | 2005 | 2019 | ||||
Chronic Periodontitis
|
99 | 0.561 | 0.760 | 6 | 32183666 | missense variant | C/T | snv | 5.3E-02 | 3.6E-02 | 0.020 | 1.000 | 2 | 2015 | 2019 |